This could partially be due to the high prevalence of obesity in Region Stockholm [13] and Sweden [11, 66], wherein a higher BMI has been reported to be significantly associated with a higher prescribing of GLP-1 RAs [67]. The gene discussed is GLP1R; the disease is obesity disorder.